As­traZeneca picks up suite of new Covid-19 an­ti­bod­ies, shin­ing spot­light on Ox­ford-tied start­up

As­traZeneca is tak­ing an­oth­er stab at de­vel­op­ing an­ti­bod­ies for Covid-19.

Hav­ing part­nered with Van­der­bilt Uni­ver­si­ty re­searchers to de­vel­op the long-act­ing an­ti­body com­bo now known as …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER